Employees: 1-10
Investment Stage: Seed
Portfolio 8
| Date | Name | Website | Total Raised | Location |
| 04.10.2022 | TRiCares G... | tricares.com | $73.39M | France |
| 13.03.2022 | Distalmoti... | distalmotion.com | $390.23M | Switzerlan... |
| 10.12.2021 | aktiia | aktiia.com | $100.47M | Switzerlan... |
| 08.07.2021 | Cardiac Su... | cardiacsuccess.com | $16.56M | - |
| 27.01.2021 | Moray Medi... | moraymedical.com | $9M | United Sta... |
| - | CorFlow Th... | corflow-therapeutics.ch | $12.32M | - |
| - | Supira Med... | supiramedical.com | $190M | United Sta... |
| - | R3 Vascula... | r3vascular.com | $87M | United Sta... |
Persons 5
| Date | First Name | Last Name | Title | Location | |||
| - | Sebastian | Wandtke | Advisory B... | linkedin.c... | - | s*********... | - |
| - | David P. | Thompson | Co-Founder... | linkedin.c... | - | d*t@415cap... | - |
| - | Linus | Rieder | Principal | linkedin.c... | - | l*r@415cap... | - |
| - | Azin | Parhizgar,... | Sr Venture... | linkedin.c... | - | a*p@415cap... | - |
| - | Michael | Braun | Senior Ven... | linkedin.c... | - | m*b@415cap... | - |
Mentions in press and media 26
| Date | Title | Description |
| 07.04.2026 | Endovascular Engineering Raises $80M Series C Funding | Endovascular Engineering, Inc., a Menlo Park, CA-based commercial-stage medical technology company, raised $80M in Series C funding. The round was led by Gilde Healthcare and Norwest, with participation from existing investors including San... |
| 24.01.2026 | TRiCares: Up To €20 Million EIB Loan Secured To Advance Topaz Tricuspid Valve Replacement Trials | TRiCares SAS, a privately held medtech company developing a minimally invasive treatment for tricuspid regurgitation, said it has signed a loan agreement for up to €20 million in non-dilutive financing with the European Investment Bank, the... |
| 28.03.2025 | Supira Medical: $120 Million (Series E) Raised For Transforming The Percutaneous Ventricular Assist Device Market | Supira Medical – a clinical-stage Shifamed portfolio company – announced the completion of an oversubscribed Series E financing round, raising $120 million to accelerate the company’s mission of transforming the percutaneous ventricular ass... |
| 12.09.2024 | CorFlow Therapeutics Secures €44 Million to Revolutionize Heart Attack Treatment | CorFlow Therapeutics is on a mission. The Swiss company has just raised €44 million in a Series B funding round, co-led by Broadview Ventures and Panakes Partners. This influx of capital is not just a financial boost; it’s a lifeline for pa... |
| 12.09.2024 | CorFlow Therapeutics raises €44 million in Series B round | Headquarted in Baar (Zug), CorFlow’s Controlled Flow Infusion (CoFI) system is being developed to provide timely, accurate and consistent detection of Microvascular Obstruction (MVO) while patients are still in the catheter laboratory (cat... |
| 12.09.2024 | CorFlow Therapeutics raises €44 million in Series B round | Co-led by Broadview Ventures and Panakes Partners, CoFlow’s series B round received strong continued support from 415 Capital, its initial VC investor and largest shareholder. Merieux Equity Partners, Laerdal Million Lives Fund, Wellington... |
| 12.09.2024 | CorFlow Therapeutics: €44 Million (Series B) Raised For Advancing Drug Delivery Platform Related To Microvascular Obstruction In Heart Attack Patients | CorFlow Therapeutics AG announced that it has raised €44 million in Series B funding, co-led by Broadview Ventures and Panakes Partners with strong continued support from 415 Capital (CorFlow’s initial VC investor and largest shareholder). ... |
| 27.07.2024 | TRiCares: Medical Device Company Raises $50 Million In Series D | TRiCares SAS, a privately held pioneer in the minimally invasive treatment of tricuspid regurgitation, announced it has raised $50 million (€46 million) in a Series D funding round. The funding round was raised from a single strategic inves... |
| 09.03.2024 | Aktiia Revolutionizes Blood Pressure Monitoring | Aktiia, a Swiss HealthTech company, secures USD 30M in funding to advance its mission of easing the global burden of hypertension through AI-driven technology. Led by Redalpine, the funding round includes investors like Khosla Ventures and ... |
| 04.03.2024 | Aktiia: Wrist-Worn 24/7 Optical Blood Pressure Monitoring Company Raises CHF 27 Million | Aktiia – the Swiss HealthTech innovator that developed the world’s first wrist-worn 24/7 optical blood pressure monitoring device – announced the completion of a CHF 27 million (USD 30M) funding round, led by Redalpine with participation fr... |
Show more